Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22439
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFujii, Tomoko-
dc.contributor.authorLuethi, Nora-
dc.contributor.authorYoung, Paul J-
dc.contributor.authorFrei, Daniel R-
dc.contributor.authorEastwood, Glenn M-
dc.contributor.authorFrench, Craig J-
dc.contributor.authorDeane, Adam M-
dc.contributor.authorShehabi, Yahya-
dc.contributor.authorHajjar, Ludhmila A-
dc.contributor.authorOliveira, Gisele-
dc.contributor.authorUdy, Andrew A-
dc.contributor.authorOrford, Neil-
dc.contributor.authorEdney, Samantha J-
dc.contributor.authorHunt, Anna L-
dc.contributor.authorJudd, Harriet L-
dc.contributor.authorBitker, Laurent-
dc.contributor.authorCioccari, Luca-
dc.contributor.authorNaorungroj, Thummaporn-
dc.contributor.authorYanase, Fumitaka-
dc.contributor.authorBates, Samantha-
dc.contributor.authorMcGain, Forbes-
dc.contributor.authorHudson, Elizabeth P-
dc.contributor.authorAl-Bassam, Wisam-
dc.contributor.authorDwivedi, Dhiraj Bhatia-
dc.contributor.authorPeppin, Chloe-
dc.contributor.authorMcCracken, Phoebe-
dc.contributor.authorOrosz, Judit-
dc.contributor.authorBailey, Michael-
dc.contributor.authorBellomo, Rinaldo-
dc.date2020-01-17-
dc.date.accessioned2020-01-20T05:24:54Z-
dc.date.available2020-01-20T05:24:54Z-
dc.date.issued2020-02-04-
dc.identifier.citationJAMA 2020; 323(5): 423-431-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/22439-
dc.description.abstractIt is unclear whether vitamin C, hydrocortisone, and thiamine are more effective than hydrocortisone alone in expediting resolution of septic shock. To determine whether the combination of vitamin C, hydrocortisone, and thiamine, compared with hydrocortisone alone, improves the duration of time alive and free of vasopressor administration in patients with septic shock. Multicenter, open-label, randomized clinical trial conducted in 10 intensive care units in Australia, New Zealand, and Brazil that recruited 216 patients fulfilling the Sepsis-3 definition of septic shock. The first patient was enrolled on May 8, 2018, and the last on July 9, 2019. The final date of follow-up was October 6, 2019. Patients were randomized to the intervention group (n = 109), consisting of intravenous vitamin C (1.5 g every 6 hours), hydrocortisone (50 mg every 6 hours), and thiamine (200 mg every 12 hours), or to the control group (n = 107), consisting of intravenous hydrocortisone (50 mg every 6 hours) alone until shock resolution or up to 10 days. The primary trial outcome was duration of time alive and free of vasopressor administration up to day 7. Ten secondary outcomes were prespecified, including 90-day mortality. Among 216 patients who were randomized, 211 provided consent and completed the primary outcome measurement (mean age, 61.7 years [SD, 15.0]; 133 men [63%]). Time alive and vasopressor free up to day 7 was 122.1 hours (interquartile range [IQR], 76.3-145.4 hours) in the intervention group and 124.6 hours (IQR, 82.1-147.0 hours) in the control group; the median of all paired differences was -0.6 hours (95% CI, -8.3 to 7.2 hours; P = .83). Of 10 prespecified secondary outcomes, 9 showed no statistically significant difference. Ninety-day mortality was 30/105 (28.6%) in the intervention group and 25/102 (24.5%) in the control group (hazard ratio, 1.18; 95% CI, 0.69-2.00). No serious adverse events were reported. In patients with septic shock, treatment with intravenous vitamin C, hydrocortisone, and thiamine, compared with intravenous hydrocortisone alone, did not significantly improve the duration of time alive and free of vasopressor administration over 7 days. The finding suggests that treatment with intravenous vitamin C, hydrocortisone, and thiamine does not lead to a more rapid resolution of septic shock compared with intravenous hydrocortisone alone. ClinicalTrials.gov Identifier: NCT03333278.-
dc.language.isoeng-
dc.titleEffect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.-
dc.typeJournal Article-
dc.identifier.journaltitleJAMA-
dc.identifier.affiliationClinical School of Medicine, University of New South Wales, Sydney, Australiaen
dc.identifier.affiliationDepartment of Intensive Care, Anaesthesia, Pain, and Perioperative Medicine, Footscray Hospital, Western Health, Footscray, Melbourne, Victoria, Australiaen
dc.identifier.affiliationService de médecine intensive et réanimation, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, Franceen
dc.identifier.affiliationIntensive Care Unit, Wellington Hospital, Capital and Coast District Health Board, Wellington, New Zealanden
dc.identifier.affiliationMedical Research Institute of New Zealand, Wellington, New Zealanden
dc.identifier.affiliationInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerlanden
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine, Kyoto, Japanen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Australiaen
dc.identifier.affiliationIntensive Care Unit, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationIntensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australiaen
dc.identifier.affiliationSchool of Medicine, Deakin University, Waurn Ponds, Victoria, Australiaen
dc.identifier.affiliationUniversity of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Intensive Care, Siriraj Hospital, Mahidol University, Bangkok, Thailanden
dc.identifier.affiliationDepartment of Intensive Care Medicine, University Hospital, University of Bern, Bern, Switzerlanden
dc.identifier.affiliationCritical Care and Perioperative Services, School of Clinical Sciences, Monash University and Monash Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationMelbourne Medical School, University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Anaesthesia and Pain Medicine, Wellington Hospital, Capital and Coast District Health Board, Wellington, New Zealand-
dc.identifier.affiliationCancer Institute of the State of Sao Paulo, Sao Paulo, Brazil-
dc.identifier.affiliationIntensive Care Unit, Wellington Hospital, Capital and Coast District Health Board, Wellington, New Zealand-
dc.identifier.doi10.1001/jama.2019.22176-
dc.identifier.orcid0000-0002-1650-8939-
dc.identifier.orcid0000-0003-4993-427X-
dc.identifier.orcid0000-0002-1650-8939-
dc.identifier.pubmedid31950979-
dc.type.austinJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

34
checked on Apr 23, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.